14 results
Pain Assessment and Management Initiative (PAMI) - Non-Opioid Analgesics - Agents and Dosing

#Management #Pain #Pharmacology #NonOpioid
Management Initiative (PAMI ... Non-Opioid Analgesics - Agents ... #Medications #Doses ... #Dosing #Table ... #PAMI
Pain Assessment and Management Initiative (PAMI) - Opioid Prescribing and Equianalgesic Chart - Agents and Dosing

#Management
Management Initiative (PAMI ... Equianalgesic Chart - Agents ... Equianalgesics #Conversion #Doses ... #Dosing #Table ... #PAMI
Pain Assessment and Management Initiative (PAMI) - Neuropathic Pain Medications:

Agent, Initiation Dose and Max Dosages

 -
Management Initiative (PAMI ... Medications: Agent ... , Initiation Dose ... #Dosing #Table ... #PAMI
Pain Assessment and Management Initiative (PAMI) - Muscle Relaxants - Agents and Dosing

#Management #Pain #Pharmacology #Muscle
Management Initiative (PAMI ... Muscle Relaxants - Agents ... #Medications #Doses ... #Dosing #Table ... #PAMI
Pain Assessment and Management Initiative (PAMI) - Nerve Blocks - Nerve Distribution, Agents and Dosing Table
Distribution, Agents ... and Dosing Table ... #Medications #Doses ... #Dosing #Table ... #PAMI
Pain Assessment and Management Initiative (PAMI) - Intranasal and Nebulized Medications- Agents and Dosing

#Management #Pain #Pharmacology
Management Initiative (PAMI ... Nebulized Medications- Agents ... #Medications #Doses ... #Dosing #Table ... #PAMI
Phosphate binders - quick reference chart of maximum daily dose. Most patients with CKD will require
maximum daily dose ... require phosphate binding ... agents since they ... are not able to ... #Dosing #Pharmacology
Potassium-Binding Agents to Treat Hyperkalemia
Sodium zirconium cyclosilicate (Lokelma):
 • Mechanism: Preferentially captures K in exchange for
Potassium-Binding ... Agents to Treat ... and sodium • Dosing ... aspiration #Potassium #Binding ... #pharmacology #table
CA-Bridge Buprenorphine Hospital Quick Start Algorithm - Management of acute opiate withdrawal 
 - Any prescriber
If patient is stable ... as first-line treatment ... Buprenorphine Dosing ... try Bup 0.3mg IV/IM ... Buprenorphine #Treatment
Myasthenia Gravis - Summary
 • an autoimmune disease of the postsynaptic neuromuscular junction associated with antibodies
serologic, and EMG findings ... characteristic EMG finding ... exacerbation at high doses ... immunosuppressant agents ... Hospital of Baltimore IM